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Abstract
Background: Polymedicated older patients are at greater risk of suffering from adverse events. For this reason, the
detection of both inappropriate polypharmacy and polypharmacy-associated Drug-Related Problems (DRPs) are
essential to improve the health and wellbeing of older adults and to reduce healthcare costs. This work aims to
explore health professionals’ perceptions and opinions about polypharmacy and the handling of medicines by
polymedicated older adults.
Methods: Thirteen focus groups with 94 health professionals (20 community pharmacists, 40 general practitioners
and, 34 nurses) were conducted in primary healthcare centers of the center region of Portugal. Participants were
asked to discuss their perceptions and beliefs concerning DRPs in polymedicated older adults. The sessions were
audiotaped. After the transcription and coding of focus group sessions, a thematic analysis was done.
Results: The following four main themes emerged from the 13 focus group sessions: poor compliance and
polypharmacy- A perpetuated vicious cycle, organization of the healthcare system, interaction and communication
between the health professionals, and strategies to prevent inappropriate polypharmacy.
Conclusions: The lack of both an efficient network of information and Interaction and communication between
Health professionals makes the detection and/ or prevention of polypharmacy in older adults difficult. The
implementation of new models to manage and/or prevent polypharmacy based on health professional perception
and beliefs is essential to prevent DRPs and improve compliance among older adults.
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Background
The world population is aging, and it is expectable that
by 2050 one in six people will be over the age of 65 [1].
Age-related loss of resilience and the progressive decline
across physiologic systems predispose older adults to
multiple chronic diseases that often require the prescrip-
tion of multiple medicines [2, 3]. Despite the efforts of
health professionals (HPs) to balance prescription and
the multiple comorbidities, drug-related hospital admis-
sion of older adults still ranges from fifteen to 30 % of
all hospital admissions [4].
United Nations defined as a worldwide priority “en-
sure healthy lives and promote well-being for all at
all ages” [1, 5].
According to a recent study, although being one of the
most aged countries in the world, only 9% of the Portu-
guese older adults were considered healthy and, almost
50% of them had difficulty complying with their medica-
tion regime [6, 7].
In the last decade, the studies on Drug-Related Prob-
lems (DRPs) have focused on medication errors commit-
ted by HPs and attributed medication errors to mistakes
in prescribing, preparation, or dispensing [8]. To our
knowledge, this is the first focus group (FG) study that
explores, in the same FG session, the beliefs and con-
cerns of pharmacists, general practitioners, and nurses
in primary healthcare centers, regarding polypharmacy
in older adult patients, as well as their opinions on how
to approach or prevent DRPs.
FG studies can be a valuable tool because they allow
the identification of all dimensions of a problem, even
those that are unexpected [9, 10]. Accordingly, this study
aimed to explore the health professionals’ perceptions
and opinions regarding both polypharmacy and the
managing of medicines by polymedicated older adults of
the center region of Portugal that is the second region
with the highest aging index (201.4) in the country [11].
This study provides valuable data for the implementa-
tion of a new healthcare model of polypharmacy man-
agement in primary healthcare systems.
Methods
An exploratory qualitative study using an FG approach
was designed to explore the perception of primary care
HP, community pharmacist (CP), general practitioner
(GP), and nurses about polypharmacy in older patients.
It was asked the collaboration of healthcare center direc-
tors to participate in the study collaborating in the invi-
tation of HPs. FG sessions were moderated by a
PharmD/ Ph.D. researcher (FR), following a guide based
on a systematic review study and drawn up by a group
of experts in pharmacology and epidemiology (Add-
itional file 1: Appendix 1) [8]. The moderator interfered
only if a topic was not directed or if the discussion came
to a stoppage. The Consolidated criteria for Reporting
Qualitative research (COREQ) were followed (Additional
file 1: Appendix 2) [12].
Setting
The FG sessions took place at 13 public health centers
coming under the Centre Regional Health Administra-
tion (Administração Regional de Saúde do Centro) and
encompassing a total of 40,835 registered older patients
(age ≥ 65 years).
Holding of focus group sessions
For each FG session were invited at least 2 CP, 2 nurses,
and 2 GP. FG sessions were conducted from May to Oc-
tober 2018 and lasted for 60–90min. They were carried
out until saturation of information was reached on the
research questions. Before the beginning of each session,
the moderator reminded the participants of the study
goals and the fact that audio records were being made of
the sessions. The moderator ensured the participants
that the content matter would remain confidential at all
times and that the data would be processed without the
identification of participants. All participants signed an
informed consent form before participation. The partici-
pation of the HPs was voluntary, without any incentives.
Analysis
All the sessions were transcribed and coded by a re-
searcher (AIP). Each session was codified with the acro-
nym FG followed by an alphanumeric character. The
participants of each session were also codified with the
acronym of their FG followed by the acronym CP for
community pharmacists, GP for general practitioner, or
N for nurses and an alphanumeric character (e.g.
FG1CP1). To guarantee trustworthiness, one month
after the last hearing, the tape was listened, once again,
and the transcription content was revised. A thematic
analysis was done, following the methodology described
by [13]. Braun and Clarke 2006) define thematic analysis
as “a method for identifying, analyzing and reporting pat-
terns (themes) within data”. “It minimally organizes and
describes data set in (rich) detail” [13]. In a first ap-
proach, and to allow a better understanding of the con-
tent of FG all the transcripts were read multiple times
by two researchers. After that, initial codes were gener-
ated and grouped into themes. Then themes were re-
vised, and data interpreted and discussed by the team,
before emerging the overarching concepts. NVivo quali-
tative data analysis software (QSR International Pty Ltd.
Version 12, 2019) was used to help with the organization
and analysis of the data.
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Results
Overall, 13 FG were conducted with a total of 94 HPs
enrolled (40 GP 20 CP and 34 nurses). The sociodemo-
graphic characteristics of the participants are summa-
rized in Table 1.
Qualitative analysis resulted in four major themes:
“poor compliance and polypharmacy- A perpetuated vi-
cious cycle”, organization of the healthcare system, inter-
action and communication between health professionals,
and strategies to prevent inappropriate polypharmacy
(Table 2).
Poor compliance and polypharmacy- a perpetuated
vicious cycle
According to HPs, aged-related comorbidities prone
older adults to multiple prescriptions, and, for this rea-
son, polypharmacy is an unavoidable consequence of
aging.
“The presence of multiple comorbidities is a normal
consequence of ageing and for this reason polyphar-
macy in older patients is common practice”,
FG5GP1.
HPs also perceive that polypharmacy and poor compli-
ance are two faces of the same coin, because polymedi-
cated older adults have difficulties to comply with the
therapeutic regime, hampering the achievement of clin-
ical outcomes and leading GPs to prescribe one more
medicine.
“Polypharmacy leads to poor compliance and the
poor compliance conduce to polypharmacy …. Be-
cause if they do not adhere to a therapeutic regime
… we prescribe for one situation, after that for an-
other problem”, FG13GP1.
Because older adults value medicines and admit that
they are essential to promote wellbeing, HPs believe that
most of the time, medication errors are unwitting and
committed due to the lack of knowledge of older adults.
“Polypharmacy is closely related to literacy”,
FG11GP1.
From this point of view, lack of literacy, sociocultural
factors, such as the absence of family and/or relatives to
take care and help with the management of medicines
are the main contributors to medication errors.
“The problem of polypharmacy is the loneliness of
the older adults that do not have any young familiar
near to help” FG2CP2.
During their daily routine, HPs perceived that because
older patients recognize medicines by the color and/or
shape of the pill, duplication mistakes, mainly due to
generic medicines confusion, or taking medicines, which
belong to others, can easily happen.
“One older woman brought to the healthcare center,
both their medicines and the medicines of their hus-
bands because they do not recognize their pills”,
FG6N3.
“There are several generic medicines for the same
active substance (from different holders) and older
patients identify the medicines by the color of the
tablet … /if a doctor prescribes to him another
medicine or deprescribes a medicine if they have
the pill at home, they will continue to take it”,
FG1CP1.
During FG sessions, it was also perceived that older
adults have some difficulties to understand the duration
of treatments, and for this reason, they tend to prolong
the treatments for more time than is recommended by
the GP. These mistakes are frequently detected in medi-
cines prescribed for an acute episode that requires an
emergency room visit.
“After an emergence visit, we frequently observed
that older patients, come to the pharmacy with a
specific medicine, and at a certain point they do not
know if they should stop or not take that medicine,
Table 1 Participants characteristics
General Practitioners
Female (n = 16) Male (n = 24) Total (n = 40)
Mean age (min; max)
46.6 (27–65) 53.0 (28–66) 50.5 (27–66)
Mean years of experience (min; max)
22.2 (1–31) 25.3 (2–40) 23.7 (1–40)
Nurse
Female (n = 32) Male (n = 2) Total (n = 34)
Mean age (min; max)
45.1 (32–63) 42.0 (38–46) 44.9 (32–63)
Mean years of experience (min; max)
25.7 (3–41) 11.5 (4–19) 18.6 (3–41)
Community Pharmacist
Female (n = 17) Male (n = 3) Total (n = 20)
Mean age (min; max)
40.8a (23–58) 30.7 (24–36) 39.11 (23–58)
Mean years of experience (min; max)
15.4 (1–34) 7.0 (1–12) 11.21 (1–34)
aTwo missing values
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and for this reason, they continue taking it”
FG1CP1.
According to HPs, difficulties related to the use of
some medicines, such as inhalators, can influence the ef-
ficacy of treatments.
“There is a lot of confusion, for example, inhalators,
they have difficulties, the device has a counter but
they don’t know, and sometimes they arrive at the
pharmacy and told us that the inhaler is empty but
is new, they do not use it”, FG2CP1.
According to HPs, the desire of older adults to achieve
wellbeing makes them easily influenced by the neighbors
or even by television commercials, potentiating the con-
sumption of over-the-counter (OTC) drugs, supple-
ments, or even herbal products. These substances
besides interfering with chronic medication might be
contraindicated for their health problems.
Table 2 Major themes from focus groups
Theme Subthemes Coding concepts
“Poor compliance and polypharmacy- A perpetuated vicious cycle”. Polypharmacy Perception


















Organization of healthcare system Medication management
directives
Healthcare directives Prescribing guidelines
Patients
empowerment
Clinical appointments Clinical appointments Lack of time
Interaction and communication between Health
professionals














Strategies to prevent inappropriate polypharmacy Prescribing managing
Generic medicines
Promotion of compliance Empowerment of
patients
Support teams
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They are easily influenced by their neighbors, which
say: I took this pill and I am feeling very well”
FG3GP1.
“Hide a lot of information, sometimes there is no
medical prescription, it was a recommendation of
the neighbors” FG1CP1.
“Several patients buy on TV calcium pills”
FG1FGP1.
HPs believe that polypharmacy per se is a contributor
to poor compliance because older adults take so many
medicines that they easily withdraw some that they be-
lieve to be less important.
“Sometimes some patients complain that they take
more medication than food”, FG1CP1.
According to HPs perception, the huge number of
pills throughout the day prompts older adults to skip
a dose, to give up some medicines that they under-
value, or that they believe might cause adverse
effects.
“Polymedicated patients always try to remove one or
another pill that they believe does not affect”,
FG3GP1.
“If someone refers to the side effects of statin, patients
automatically stop taking”, FG8GP1.
During their practice, GPs perceived that fake beliefs
of older adults make the deprescription of medicines
difficult.
“Deprescribing some medicines it was almost impos-
sible, for example, trimetazidine is very, very hard”,
FG3GP1.
“If I want to deprescribe pills that the patient is tak-
ing to 30 or 25 years, with which they felt good … we
understand that it’s causing more harm than good
… it is very difficult”, FG5GP2.
Another important compliance-influence factor that
emerged during the FG discussions was the price of
medicines.
“The price of the medicines also contributes to poor
adherence” FG1GP1.
According to HPs, patients with economic problems,
adjust the therapeutic regimen to spend less money.
“… a large number of older adults that take oral an-
ticoagulants, the new ones that are more expensive,
sometimes instead of taking two pills only take one”
FG4GP3.
However, some HPs also pointed out that the Portu-
guese National Health System (NHS) is predominantly
financed by taxes and some out-of-pocket payments that
include co-payment for a wide range of services, though
there are income-based exemptions population groups
(and certain medical conditions). Portuguese older adults
with an average salary of 1.5 times below the value of
the social support index are exempt from co-payment
for any publicly provided services. For these reasons,
some HPs affirms that sometimes the low price of medi-
cines promotes the wastage of health resources.
“Low price of some medicines, namely insulin pro-
motes the wastage of health resources because pa-
tients tend to open new insulin before the first
finished, and put the older on the garbage” FG2CP1.
During FG sessions, it was perceived that the lack of
communication between patients and physicians is not
only an important polypharmacy-related factor but also
an influencer of compliance. Because patients do not re-
port to their GP either the specialist appointments that
they had or the new prescriptions or other products that
they take, inappropriate polypharmacy is harder to detect.
“… older adults do not report their specialist/ emer-
gency room visits to the GP, for these reasons’ GP
has difficulties in detecting this inappropriate poly-
pharmacy” FG1GP5.
“Teas herbal products and other blend beverages
that patients buy here or there because of their
health problems... One for the gallbladder, one an-
other to the head, other to the kidney, and all of
these substances have an active substance. All of
them can cause drug interactions …. That we cannot
control” FG5GP1.
Organization of the healthcare system
HPs perceived that the organization of the healthcare
centers doesn’t simplify the identification of DRPs.
Within this theme, two subthemes emerged, i.e. “Medi-
cation management directives” and Clinical
appointments.
Medication management directives
HPs believe that the lack of centralization of patients
chronic medication compromises clinical outcomes and
promotes duplication mistakes.
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“The lack of centralization of chronic medication
management is a problem, because we have many
vulnerable older patients … , who have several phy-
sicians’ appointments, consequently to many pre-
scribers, both in the public and private sector. These
physicians have very great freedom to prescribe,
which makes that the physician where all the infor-
mation should converge, theoretical the GP, have dif-
ficulties in handling and evaluate all the prescribed
medication …. And this then generates situations
such as polypharmacy, adverse reaction, drug inter-
action”, FG1GP1.
NHS guidelines recommend that HPs “must privilege
the use of electronic means to support the processes of
prescribing, dispensing and billing of all types of medi-
cines, as well as health products” [14]. For this reason,
the prescription and the treatment guide are sent by
SMS (short message service) to the mobile phone. Ac-
cording to HPs, these directives make the empowerment
of patients on medication management difficult.
“I think, there is some pressure for physicians to stop
printing the treatment guide …. The older popula-
tion needs the guide treatment written in a paper”,
FG5N1.
“Into the older population that has a cell phone,
some do not know how to use it, and when they want
to see the treatment guide sometimes, they press the
wrong button and once upon a time a treatment
guide, they delete all”, FG5N2.
Clinical appointments
According to HPs, the short time of the clinic appoint-
ments’ hampers not only the therapeutic review process
but also the review of the handling of medicines by older
adults.
“The 15 minutes of clinic appointment turns out to
be little to explore these issues”, FG13GP2.
HPs also refer that the lack of time during clinic ap-
pointments is an important polypharmacy-related factor
that sometimes is undervalued.
“It takes time to see all … and we do not have time”
FG2GP5.
Interaction and communication between health
professionals
Within this theme, two subthemes emerged, i.e. lack of
time to communicate and external responsibilities.
Lack of time to communicate
HPs believe that in some healthcare centers the inter-
action among HPs promotes the detection of DRPs.
“… yesterday, a pharmacist called to tell me that a
patient bought a statin different from what I had
prescribed, I appreciate that”, FG4GP3.
However, when managing patients’ therapeutics, this is
not always a reality.
“There are units that make protocols with local
pharmacies … the problem is the lack of time”
FG1GP1.
“… must-have big management of medicines, and for
this is necessary do therapeutic revisions and pres-
ently GP, perhaps because they lack time, they are
not doing it”, FG2CP3.
In Portugal, primary healthcare centers are the gate-
keeper of the NHS, so, whenever a patient needs a spe-
cialist appointment, the GP requests the appointment
and sends all the clinical processes of the patients to the
specialist. During FG sessions, it was perceived that it is
hard to obtain the return information, suggesting that
there is a lack of communication between GPs and the
other physicians.
“… we are obliged, and even if we were not, we al-
ways send complete information with the medication
with everything, and then we never get the return”,
FG4GP1.
“Sometimes happens patients are taking an active
substance for hypertension prescribed by the GP,
therefore prescribed by myself, in the meanwhile, for
any reason they go to the emergency service and
comes to the home with other hypertensive medicines
from another chemical group, which must not be
taken with the previously prescribed hypertensive.
Because physician, that works at the emergency ser-
vice, did not take the trouble to see the chronic
medication of the patients, the patients take the
pills”, FG10GP1.
This lack of time to communicate becomes more de-
manding in circumstances such as the deprescribing
process.
“I do not feel comfortable to remove some medi-
cines, a cardiologist appointment, patients expect
eternity, so they go to a private clinic and, if I
call the cardiologist, he will say if you want to
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remove the medicine do it, but is your responsibil-
ity”, FG10GP5.
External responsibilities
The lack of time to communicate promote misunder-
standings among HPs and they tend to assign responsi-
bility to others. According to GPs, CPs are not doing
their job because before selling a medicine they should
ensure that patients know how to use the medicines.
If patients have, doubts are pharmacist faults ….
They must explain well because they sell the medi-
cines, they have all the material”, FG10GP3.
GPs also affirm that some duplication mistakes occur,
because CPs replace the original medicines, which they
prescribed, with generic medicines. On the other hand,
CPs feel undervalued by physicians who tend to forget
their role and the fact that their proximity to older pa-
tients makes them know patients’ needs better. More-
over, CPs affirm that when selling a generic medicine,
they do it responsibly and because they know the eco-
nomic context of the patient.
“What happens is that GP does not have the per-
spective of the price of medicines, and they prescribe
medicine and, when the patient came to the phar-
macy they ask us if we do not have a cheaper medi-
cine, “I do not have money to buy this …” / we are
not changing the therapeutic, we are first helping the
patients” FG10CP2.
Strategies to prevent inappropriate polypharmacy
According to HPs, polypharmacy could be reduced if
GPs were able to act as the manager of all prescriptions,
i.e. GP should have the opportunity to validate/ or not a
prescription, prescribed by other physicians, before the
dispensing.
“All the prescription must have to be authorized and
validated by the GP, that managing and planning
the health of the patient”, FG1GP1.
During FG sessions it was perceived that HPs admitted
that the introduction of the.
Electronic prescription of medicines (PEM) promotes
the managing of medicines; however, this platform had
some gaps that make the detection of DRPs a hard task.
GPs affirmed that when using PEM, they find difficulties
in updating chronic medication. They also believed that
all HPs should have access to this platform. HPs believe
that the limited access of PEM to the nurses hampers
their role in DRPs detection. Moreover, CPs could also
have a more active role in DRPs detection, if they could
access PEM. CPs could relieve the burden of primary
healthcare centers in terms of time and duration of clin-
ical appointments, through the opportunity to renew the
chronic medication.
“If the PEM allows the update of chronic medication
and if pharmacists could access the PEM, the
pharmacist can make the renewal of the chronic
medication and, this in turn, relieve the burden that
physicians have in terms of patient appointment”
FG1GP1.
To avoid DRPs related to duplication of medicines,
HPs suggested that the pharmaceutical industry should
agree to standardize the boxes of medicines and even, if
possible, the color and form of pills by active substance.
“The boxes of the same active principle should have the
same color …” FG1GP2.
“the pills should also be standardized in terms of
shape and color, FG1N1.
Lastly, health professionals believe that to decrease
DRPs it is essential to support, empower the patients
and promote health literacy.
“The ideal would be to have a support team not only
to make the dressings and emergencies but also to
visit the needy patients that live alone. Older adults
often do things on their way because they don’t want
to ask for help and they don’t have support either...
The support would be to try to understand if the
medication is being well managed”, FG5N1.
“The user comes to the health center, takes the pre-
scription I can even know if he raised the boxes in
the pharmacy, but on the home visit, I can find a
warehouse of boxes of medicines”, FG5GP1.
“Promote health literacy”, FG3GP2.
“The awareness campaigns could be a good help to
patients and healthcare professionals”, FG5N1.
Discussion
Worldwide, one of the consequences of the demographic
trends in ageing was the increasing number of ageing-
related comorbidities. Because of that, the implementa-
tion of new models to deal with the consequences of
polypharmacy is fundamental not only to ensure the
welfare of the older population but also to guarantee the
efficacy of healthcare systems. From this point of view,
understanding HPs perceptions and beliefs is
fundamental.
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To our knowledge, this is the first FG study that en-
compasses a multidisciplinary team of HPs (physicians,
nurses, and pharmacists in the same FG session), who
daily take care of polymedicated older adults, to explore
their perception and opinions regarding polypharmacy-
associated DRPs in older adults.
HPs believe that the economic/ social context of older
adults influences their behavior, and, in cases of low lit-
eracy, low mensal incomes, and lowliness, it can trigger
the occurrence of DRPs. The short time of clinical ap-
pointments, the lack of time to communicate and net-
work between all HPs, the poor communication between
HPs and patients were identified as the main gaps in the
healthcare system that difficult for both the managing of
polypharmacy and the detection of DRPs. The decrease
of the gaps mentioned above and the empowerment of
polymedicated older adults can have positive effects on
patient health outcomes through the improvement of
compliance and the reduction of DRPs.
During FGs sessions, we perceived that overall; the dif-
ferent HPs have complementary and frequently similar
answers. However, HPs tend to assign responsibilities to
other HPs, CPs affirm that GPs are not doing their work
on the therapeutic review, and GPs believe that CPs are
not due to their work on counselling patients. CPs also
affirm that they do their best the managing their pa-
tients, and they make an effort to manage each patient
according to patients’ socio-economic reality and argue
that GPs do not value their work.
Due to the overload of the Portuguese NHS, patients
wait months or even years for a specialist appointment.
This waiting time together with the overwhelmed that
Portuguese physicians’ feelings are, according to our per-
ception, the main reasons for the inappropriate commu-
nication between physicians and a source of
misunderstanding. This situation becomes more de-
manding because, in some situations, patients instead of
waiting for a specialist appointment opt to go to a pri-
vate clinic and, they do not report these appointments
to GP.
Our study participants consider that the presence of
multiple comorbidities associated with the fact that the
guidelines are based on single chronic diseases makes
polypharmacy a recurrent issue among older adults.
Moen et al. [15] reported that although physicians trust
in guidelines, sometimes they felt insecure because older
people are underrepresented in the studies on which the
guidelines are based. For this reason, physicians perceive
that following guidelines for some diseases, such as car-
diovascular diseases, might prompt the occurrence of
polypharmacy [8]. Our results also showed that polyme-
dicated older adults more easily fall into a “prescription
cascade”. This phenomenon was observed in clinical
practice for the first time by Rochon et al. in 1995 [16,
17]. During our study, HPs also reported that polyphar-
macy potentates the occurrence of interactions and they
felt that they are “walking on thin ice”. Our study dem-
onstrated that media, websites and even patients’ peers
frequently gave patients “a false awareness of knowledge
about medicines and because of that, patients tend to
pressure HPs to obtain the products that they wish, and
not what they need [18, 19]. A recent FG study [20] ob-
served that older patients trust in HPs, and believed that
they play a determinant role to ensure the correct man-
aging of medicines and decreasing DRPs. However, older
adults also admitted that sometimes they decide not to
comply with the therapeutic regime, due to influences of
family and friends, television commercials, fear of an ad-
verse reaction, etc., and they do not share their decision
with health professionals [20]. These observations are
following our study since HPs perceived that older
adults hide a considerable amount of information re-
garding the adaptation of the therapeutic regimen ac-
cording to friend opinion and the consumption of herbal
products. Both HPs and patients [20] perceived that: (i)
the influence of friends and television advertisements
potentiate the consumption of supplements and other
products, such as herbal products, which might prone
them to quit their prescription medicines; (ii) the lack of
knowledge of older patients and the absence of care-
givers to help with the management of medicines im-
prove both medication errors and poor compliance with
consequently poor health outcomes; (iii) Because older
patients recognize their medicines by color and shape,
the lack of standardization of dosage forms, color and
packaging, the change of trade mark drugs for generic
drugs or changes of generic drugs holders, is enough for
older adults to commit treatment duplication errors
when they handle generic medicines. This observation
was found in a previous study [21], (iv) older patients at-
tach great value to their medicines, however, when they
take many medicines, they weigh the risks and benefits
and might stop taking some, (v) older patients trust in
their HP, but they believe that there is no need to share
the use of other products (like OTC) with the GPs; this
purposeful omission of information influences treatment
efficacy and makes the detection of DRPs difficult. Ac-
cording to Pound et al. [22] patients believe that flexibil-
ity in taking their medication allows life to continue
without too many disruptions.
Safran et al. [23] reported that older adults with fewer
resources are less compliant and tend to skip doses to
make their medicines last longer. Einav et al. [24] ob-
served that individuals tend to consume less healthcare
when they are required to pay more for it out of pocket;
suggesting that moral hazard in health insurance exists.
Moreover, an Irish study observed that insured older
adults tend to experience more polypharmacy than not
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insured older adults [25]. In older adults from Korea, it
was observed that the low-income status associated with
the coinsurance payment policy could trigger a large
medication cost burden [26]. To avoid a medication cost
burden, the co-payments on Portuguese NHS include
exceptions and people with certain medical conditions
and older adults with low incomes are exempt from co-
payment for publicly provided services [27–29]. More-
over, the co-payments for medicines ranging from 15 to
90% of co-insurance are applied according to their thera-
peutic value. In some of the most aging cities of
Portugal, regional governments implemented measures
to support the cost of medicines for older adults with
low incomes [27–29]. For these reasons, we believed that
low incomes could influence therapeutic adherence, but
the lack of health literacy and the poor empowerment of
the patients influence even more. Previously studies re-
ported that there are problems when transferring infor-
mation between healthcare facilities and that this
problem is critical when they intend to deprescribe med-
icines [30–33]. For this reason, the development of
deprescribing approaches is essential for optimizing
medication management and reducing polypharmacy in
older adults [34, 35].
We believe that the development of health policies di-
rected to polypharmacy as well as the implementation of
computerized clinical decision support systems [36] will
not only facilitate the managing of polymedicated older
adults by GP but also avoid DRPs such as medicines du-
plication and drug interactions. As previously reported
[37] we believe that CPs could also have a more active
role not only in minimization of duplication mistakes
due to patients’ confusion, but also to promote the trust
of the patient in generic medicines and perhaps improve
medication due to the lower price of generics.
This study has some limitations linked to the chosen
methodology. FG participants were invited/ selected by
healthcare center directors, the results cannot be gener-
alized to the whole population, timid participants have
more difficulty to share their perceptions, and partici-
pants may follow the general trend to give similar an-
swers. This methodology’s generalizability is best judged
in both exploring the perception of the participants and
to favor the arising of a new topic [38]. This method-
ology also has the advantage to promote the interaction
of all participants, facilitating the communication of the
timidity participants. Because the convenience sampling
used, selected based on the individual characteristics of
the overall population, this methodology can contribute
to helping researchers gain a greater understanding of
the research question rather than from a statistically rep-
resentative of a broader population [39]. To decrease
limitations associated with FG methodology, FG sessions
were undertaken at several healthcare centers located
across inland and coastal areas of the Portugal center re-
gion [40]. All sessions were moderated by the same
moderator.
Conclusions
Portuguese GPs feel overwhelmed and for this reason,
they do not have time to revise the therapeutic of their
patients. To minimize DRPs-associated polypharmacy in
older adults, GPs, nurses, and CPs should interact to fa-
cilitate the therapeutic review. The strengthening of
communication among HPs, between HPs and patients
and the improvement of literacy of older adults regard-
ing the managing of their medicines is essential to en-
hance health outcomes among polymedicated older
adults.
In 2018, our group initiated the MEdElderly project to
improve drug managing among the older population of
Portugal’s center region. The results of this FG study
were useful to design an educational intervention that
aims to address the main DRPs observed in older adults,
demystify false beliefs and promote the correct manage-
ment of medicines.
Supplementary Information
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